Skip to main content

Table 2 Levels of sCD138 and time frame of sample collection in patients with HFRS

From: Study on expression of plasma sCD138 in patients with hemorrhagic fever with renal syndrome

 

Mild group

(n = 32)

Moderate group

(n = 50)

Severe group

(n = 43)

Critical group

(n = 51)

Control group (n = 35)

sCD138, ng/mL

 a Acute stage

3.45 ± 2.32

5.29 ± 3.64

4.73 ± 3.83

5.22 ± 3.19

0.819 (0.260)

 b Convalescent stage

2.71 ± 2.45*

2.78 ± 1.39*

2.54 ± 1.68*

2.56 ± 2.58*

0.819 (0.260)

Length of time (days)

 c Acute stage

7 (4)

7 (3)

7 (3)

7 (4)

–

 d Convalescent stage

11.5 (4)

13 (3)

17 (10)

22 (10)

–

  1. aKruskal-Wallis H test: χ2 = 89.367, P<0.001. b Kruskal-Wallis H test: χ2 = 75.894, P<0.001
  2. cKruskal-Wallis H test: χ2 = 5.612, P = 0.312. d Kruskal-Wallis H test: χ2 = 45.344, P<0.001
  3. *Comparison of the levels of sCD138 between the acute and convalescent stage: mild group, t = 0.873 P = 0.387; moderate group, t = 4.253 P<0.001; severe group, t = 3.253 P = 0.002; critical group, t = 3.748 P<0.001
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us